Obesity and Weight Loss Strategies

NB: We do not resell your papers. Upon ordering, we do an original paper exclusively for you.

NB: All your data is kept safe from the public.

Table of Contents

Introduction
OTC Product and Diet
Reflection
Conclusion
References

Introduction

The obesity epidemic is among the most urgent healthcare issues in the United States and worldwide. According to recent estimations, between 39% and 49% of the world’s population are overweight or obese nowadays (Powell-Wiley et al., 2021). This trend has led to many people seeking weight loss through different means, including diet, eating behavior management, and pharmacological weight loss agents (Kushner, 2018). However, over-the-counter (OTC) weight loss products have also gained popularity despite serious health risks (Rodriguez-Guerra et al., 2021). Therefore, it is essential for healthcare professionals to keep the broad public well-informed about the nature and potential adverse effects of such products.

OTC Product and Diet

The model client is a 40-year-old man with a family history of obesity-related cardiovascular disease. The client pursues weight loss primarily out of concerns for personal health due to recently developed hypertension. The client has considered using an OTC, non-prescription herbal weight loss supplement, AMPK Metabolic Activator. The drug is advertised as a mixture of two botanical components that supposedly help the body burn stored abdominal fat (AMPK Metabolic Activator, n. d.). The patient’s product choice was primarily driven by the desire to achieve quick weight loss using natural products instead of synthetic medications.

However, the client was strongly advised against using OTC products due to a broad range of associated health hazards. Despite advertisement, most OTC herbal weight loss drugs are adulterated with active pharmaceutical agents (Dastjerdi et al., 2018). The pharmaceutical components in such products include tramadol, caffeine, fluoxetine, rizatriptan, venlafaxine, and methadone (Dastjerdi et al., 2018). Legal in most countries, these agents present serious health risks in case of excessive consumption. Furthermore, sibutramine, associated with a high risk of cardiovascular diseases even among consumers without a known history of CVDs, remains in many herbal medications (Rodriguez-Guerra et al., 2021). Therefore, the list of potential negative side-effects of the OTC weight loss products contradicts the client’s initial expectations and desires.

A healthier and more effective weight loss strategy is changing the lifestyle. Healthcare experts agree that weight loss depends primarily on reducing total caloric intake and sufficient physical activity (Kushner, 2018). Additionally, this strategy helps prevent a broad range of cardiovascular diseases and improves the overall physical condition. Therefore, a diet based on the client’s metabolic profile and health condition is the strategy’s primary focus. Experts recommend the calorie-reduced Dietary Approaches to Stop Hypertension (DASH) diet, rich in fruits, vegetables, and low-fat dairy products, for patients with hypertension (Kushner, 2018). The proposed day 1 menu would consist of the following:

a whole-wheat bagel with 2 tablespoons peanut butter, an orange, and a cup of fat-free milk for breakfast;
spinach salad with reduced-sodium wheat crackers for lunch;
baked cod with 1/2 cup brown rice pilaf with vegetables, 1/2 cup fresh green beans, and herbal tea for dinner (Sample menus for the DASH diet, 2020).

This diet corresponds to the client’s goals and is optimal for his health profile.

Reflection

Intermittent fasting (IF) has become an increasingly popular approach to treating obesity. Its proponents argue that the strategy is more effective in addressing weight loss than traditional daily caloric intake reduction (Halpern & Mendes, 2021). The IF advocates claim that high insulin levels in the organism associated with high carbohydrate intake facilitate the development of obesity. Intermittent fasting addresses this issue by reducing insulin levels via specially developed fasting schedules. However, experimental models in animals and humans have repeatedly discredited the insulin-related theory (Halpern & Mendes, 2021). Nevertheless, many people still see IF as a preferable alternative, mainly due to its widely marketed supposed benefits and the absence of strict dietary limitations and excessive physical activity.

Conclusion

Obesity remains a significant public health hazard globally, requiring the development and broad introduction of efficient and affordable weight loss strategies and programs. While many still resort to OTC medications and other questionable weight loss strategies, public health professionals and institutions must promote evidence-based approaches. These include safe, personally developed, balanced dietary measures, prescription pharmaceutical agents, and a healthy lifestyle with sufficient physical activity and caloric intake.

References

AMPK Metabolic Activator (n. d.). Life Extension. Web.

Dastjerdi, A. G., Akhgari, M., Kamali, A., & Mousavi, Z. (2018). Principal component analysis of synthetic adulterants in herbal supplements advertised as weight loss drugs. Complementary Therapies in Clinical Practice, 31, 236–241. Web.

Halpern, B., & Mendes, T. B. (2021). Intermittent fasting for obesity and related disorders: unveiling myths, facts, and presumptions. Archives of Endocrinology and Metabolism, 65(1). Web.

Kushner, R. F. (2018). Weight Loss Strategies for Treatment of Obesity: Lifestyle Management and Pharmacotherapy. Progress in Cardiovascular Diseases. Web.

Powell-Wiley, T. M., Poirier, P., Burke, L. E., J.-P., Després, Gordon-Larsen, P., Lavie, C. J., Lear,S. A., Ndumele, C. E., Neeland, I. J., Sanders, P., & St-Onge, M.-P. (2021). Obesity and cardiovascular disease: A scientific statement from the American Heart Association. Circulation, 143(21), 984–1010. Web.

Rodriguez-Guerra, M., Yadav, M., Bhandari, M., Sinha, A., Bella, J. N., & Sklyar, E. (2021). Sibutramine as a cause of sudden cardiac death. Case Reports in Cardiology, 2021, 1–5. Web.

Sample menus for the DASH diet(2020). Mayo Clinic. Web.

Click Here To Order Now!

Obesity and Weight Loss Strategies

Do you need this or any other assignment done for you from scratch?

We have qualified writers to help you.

We assure you a quality paper that is 100% free from plagiarism and AI.

You can choose either format of your choice ( Apa, Mla, Havard, Chicago, or any other)